379 results
Page 6 of 19
424B5
0ytlg ad1c4g6ran6
31 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
rfeswy95e4
30 Oct 13
Prospectus supplement for primary offering
12:00am
8-K/A
c9xe ihhxuug96ay
25 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
a5lu8 naehx4
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
fjfc9
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
mu8p8rz
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
8-K/A
pfhea kgn
14 Jun 13
Financial Statements and Exhibits
12:00am
8-K
165v6lj37qnm7
10 Jun 13
Discovery Labs Responds to FDA Request for Clarification of Recently
12:00am
424B5
q2lby3z99i
9 May 13
Prospectus supplement for primary offering
12:00am
8-K
jc8t3v4 bpgc
7 May 13
Discovery Labs Reports First Quarter 2013 Financial Results
12:00am
8-K
xvzw6rl6ut5h1n
15 Apr 13
Other Events
12:00am
8-K
k41rw l498kg7z
2 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
ozjzec4fggi7
15 Mar 13
Financial Statements and Exhibits
12:00am
8-K
eqba bys3q46up
13 Mar 13
Discovery Labs Reports Fourth Quarter 2012 Financial Results
12:00am